DIA
Drug Information Association Logo

Implementation of the Physician Payments Sunshine Act: Now What?

Wednesday, June 27
3:30-5:00 PM ET

This controversial provision of the Affordable Care Act has its proponents and its critics.  As it goes into effect, this influential panel will focus on its likely impact on the public health and all the stakeholders – government, lawyers and accountants, the pharmaceutical and medical device industries, researchers and investigators, physicians, and others. Representing a cross-section of interest areas, the panelists will take a serious look at the burdens and benefits, the potential impact on clinical research, the advantages offered by the resultant transparency, and how all of this will play out within the public and organized medicine.

Moderator

 
John F. Kamp, JD, PhDJohn F. Kamp, JD, PhD
Executive Director, Coalition of Healthcare Communication
 

Panelists

 
 Daniel J. CarlatDaniel J. Carlat, MD
Director, Pew Prescription Project
The Pew Health Group
The Pew Charitable Trusts
Sandra J. P. Dennis, JD Sandra J. P. Dennis, JD
Deputy General Counsel, Biotechnology Industry Organization (BIO) 
John J. Lewis, MA John J. Lewis, MA
Vice President, Public Affairs, Association of Clinical Research Organizations 
Marjorie E. Powell, JD Marjorie E. Powell, JD
Senior Assistant General Counsel
PhRMA 
Thomas P. Stossel, MDThomas P. Stossel, MD
American Cancer Society Professor of Medicine, Harvard Medical School
Director, Translational Medicine Unit and Center for Medical Innovation, Brigham & Women’s Hospital 
 
© 2014 DIA